Brokerages Set National Health Investors, Inc. (NYSE:NHI) PT at $60.50

National Health Investors, Inc. (NYSE:NHI) has been given an average recommendation of “Moderate Buy” by the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and four have given a buy rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $60.50.

A number of equities analysts recently issued reports on NHI shares. Deutsche Bank Aktiengesellschaft started coverage on National Health Investors in a report on Tuesday, January 30th. They set a “buy” rating and a $69.00 price objective for the company. StockNews.com cut shares of National Health Investors from a “buy” rating to a “hold” rating in a report on Thursday, April 18th. Truist Financial raised their price target on shares of National Health Investors from $55.00 to $58.00 and gave the stock a “hold” rating in a research note on Thursday, April 4th. Wells Fargo & Company raised shares of National Health Investors from an “equal weight” rating to an “overweight” rating and boosted their price objective for the company from $55.00 to $63.00 in a research report on Monday, February 26th. Finally, BMO Capital Markets raised shares of National Health Investors from a “market perform” rating to an “outperform” rating and set a $67.00 price target for the company in a research note on Tuesday, March 12th.

National Health Investors Stock Down 0.7 %

Shares of NYSE:NHI opened at $64.25 on Thursday. The company has a debt-to-equity ratio of 0.90, a current ratio of 10.27 and a quick ratio of 10.27. The business has a 50 day simple moving average of $60.67 and a two-hundred day simple moving average of $56.36. National Health Investors has a 1 year low of $48.51 and a 1 year high of $65.23. The firm has a market capitalization of $2.79 billion, a PE ratio of 20.53 and a beta of 0.95.

National Health Investors Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Friday, May 3rd. Investors of record on Thursday, March 28th were issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 5.60%. The ex-dividend date of this dividend was Wednesday, March 27th. National Health Investors’s payout ratio is 115.02%.

Insiders Place Their Bets

In related news, Director Charlotte A. Swafford purchased 10,000 shares of National Health Investors stock in a transaction dated Tuesday, February 27th. The stock was purchased at an average cost of $58.69 per share, with a total value of $586,900.00. Following the transaction, the director now owns 110,185 shares in the company, valued at approximately $6,466,757.65. The purchase was disclosed in a document filed with the SEC, which is available through the SEC website. 8.21% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in National Health Investors by 5.7% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 21,944 shares of the real estate investment trust’s stock valued at $1,127,000 after acquiring an additional 1,190 shares in the last quarter. International Assets Investment Management LLC boosted its position in shares of National Health Investors by 3,690.7% in the 4th quarter. International Assets Investment Management LLC now owns 28,430 shares of the real estate investment trust’s stock worth $1,588,000 after purchasing an additional 27,680 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. grew its stake in National Health Investors by 4.6% during the 4th quarter. Mirae Asset Global Investments Co. Ltd. now owns 189,221 shares of the real estate investment trust’s stock worth $10,568,000 after buying an additional 8,316 shares during the last quarter. Vanguard Group Inc. increased its position in National Health Investors by 0.4% during the 3rd quarter. Vanguard Group Inc. now owns 6,173,352 shares of the real estate investment trust’s stock valued at $317,063,000 after buying an additional 22,443 shares in the last quarter. Finally, Raymond James Financial Services Advisors Inc. raised its stake in National Health Investors by 14.4% in the fourth quarter. Raymond James Financial Services Advisors Inc. now owns 30,971 shares of the real estate investment trust’s stock valued at $1,730,000 after buying an additional 3,907 shares during the last quarter. Hedge funds and other institutional investors own 62.51% of the company’s stock.

About National Health Investors

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.